Cellectis (CLLS) Payables (2013 - 2026)
Cellectis' Payables was $18.2 million in Q2 2026, up 3.9% from $17.52 million a year earlier and up 6.5% from the prior quarter.
Powered by 
Analysis
Cellectis (CLLS) Payables (2013 - 2026) Analysis & Trends
At the end of FY2025, Payables at Cellectis came in at $17.28 million, down 7.4% from FY2024.
- Payables has now declined for six consecutive years, with a five-year compound annual growth rate of -6.8% (FY2020 to FY2025).
- In earlier years, Payables was $18.66 million in FY2024 (-2.1%), $19.07 million in FY2023 (-11.1%), $21.46 million in FY2022 (-9.7%) and $23.76 million in FY2021 (-3.4%).
- The Q2 2026 figure marks the highest quarterly Payables since Q4 2024.
- Compared with a year earlier, Payables was higher in two of the last eight quarters, with an average decline of 3.2%.
- The best year-over-year quarter for Payables over five years was Q1 2025 (growth of 7.2%); the worst was Q3 2021 (a decline of 34.8%).
- Per Business Quant data, CLLS's Payables in the three quarters before Q2 2026 was $17.09 million (Q1 2026), $17.28 million (Q4 2025) and $16.1 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 6.11 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 20.92 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 33.30 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 5.96 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 4.26 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 22.89 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 2.87 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 674.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 7.03 Bn |
| 10 | Cellectis | 98.28 Mn | -655.11 Mn | - | 18.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 18.20 Mn |
| Mar 31, 2026 | 17.09 Mn |
| Dec 31, 2025 | 17.28 Mn |
| Sep 30, 2025 | 16.10 Mn |
| Jun 30, 2025 | 17.52 Mn |
| Mar 31, 2025 | 17.21 Mn |
| Dec 31, 2024 | 18.66 Mn |
| Sep 30, 2024 | 18.51 Mn |
| Jun 30, 2024 | 18.21 Mn |
| Mar 31, 2024 | 16.05 Mn |
| Dec 31, 2023 | 19.07 Mn |
| Sep 30, 2023 | 20.48 Mn |
| Jun 30, 2023 | 19.23 Mn |
| Mar 31, 2023 | 22.32 Mn |
| Dec 31, 2022 | 21.46 Mn |
| Sep 30, 2022 | 22.35 Mn |
| Jun 30, 2022 | 24.16 Mn |
| Mar 31, 2022 | 20.92 Mn |
| Dec 31, 2021 | 23.76 Mn |
| Sep 30, 2021 | 22.81 Mn |
API Access
Cellectis Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=CLLS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "CLLS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=CLLS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();